Skip to main content

Abel Makubi (36870358/2023)

Paper Title

Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial.

Pubmed ID
36870358
Date
2023/03/31
Member Group
SPARCo Tanzania
Member Name
Abel Makubi
First Author
Emmanuela E Ambrose
First Author Affiliation
Department of Paediatrics and Child Health, Catholic University of Health and Allied Sciences, Mwanza, Tanzania
Last Author
Luke R Smart
Last Author Affiliation
Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA